Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Bile-Binding Foods to Reduce Upper Gastrointestinal Bile Acid Concentrations
NCT07303868Phase 4Not yet recruiting
- Sponsor
- Boston Children's Hospital
- Start
- Oct 2026
- Primary completion
- Aug 2030
01
Overview
Phase 4, randomised, open-label trial (3 arms), sponsored by Boston Children's Hospital. Primary endpoint: Gastric bile acid concentration at 2 weeks. Planned start Oct 2026; status: not yet recruiting.
Beyond the preview
Go deeper on NCT07303868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07303868.